Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by:
Helsinki University
ClinicalTrials.gov Identifier:
NCT00117299
First received: June 30, 2005
Last updated: May 25, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)